Cervical Cancer

The FDA granted priority review to cemiplimab-rwlc for treatment of certain women with advanced cervical cancer.

Women who miss cancer screenings face higher morbidity and mortality risks, and race may indicate who is more likely to get those screenings, according to a study presented at the North American Menopause Society Annual Meeting.

The FDA granted accelerated approval to tisotumab vedotin-tftv for certain women with advanced cervical cancer.

The addition of pembrolizumab to chemotherapy, with or without bevacizumab, significantly improved PFS and OS among women with persistent, recurrent or metastatic cervical cancer, results of the randomized phase 3 KEYNOTE-826 study showed.

While on-site at a same-day cancer screening program he helped to implement, Timothy Craig Allen, MD, JD, FCAP, came across a crying woman.

A history of HPV vaccination may not reliably help physicians triage women for less intensive management after an abnormal cervical screening test result, according to researchers.

Many transgender men and nonbinary people assigned female at birth, or TMNB, reported barriers to cervical cancer screening, according to results of a cross-sectional survey of these underserved populations.

Although 5-year survival rates have increased for multiple cancer types among adolescents and young adults, little or no improvement has been observed for some common malignancies in this population, according to findings published in Cancer.

In this video, Christina M. Annunziata, MD, PhD, senior investigator at the National Cancer Institute, discussed the “practice-changing” results from the OUTBACK trial.

An alkylating mutational signature in colon cells appeared to be associated with red meat consumption and certain cancer driver mutations, according to a recent study. An interview with one of the authors was the top story in hematology/oncology last week.